Last edition
News about "Chiesi "
Chiesi Secures UK Approval for World's First Low-Carbon pMDIs Using Next-Generation Propellant
MHRA authorises Clenil Modulite inhalers with a non-PFAS, low global warming potential propellant, reducing carbon emissions by up to 90 percent while maintaining therapeutic efficacy.
Chiesi | 23/07/2026 | By News Bureau
Avanzanite Bioscience Welcomes Dr Mark Bechter as SVP Medical Affairs
Dr Mark Bechter joins Avanzanite Bioscience as SVP of Medical Affairs, marking sixth key leadership hire in 2025 to advance rare disease access across Europe.
Chiesi | 10/09/2025 | By Dineshwori | 222
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy